Moreover, AZD7762, an inhibitor of CHK1, has been proven to enhance DDP cytotoxicity and to overcome DDP resistance in small cell lung cancer, osteosarcoma, and other malignant tumors.13,14. The gene discussed is CHEK1; the disease is cancer.